
Concord Biotech Ltd is Rated Sell
2026-11-21 10:10:33Concord Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 Oct 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 November 2026, providing investors with the latest insights into its performance and outlook.
Read More
Concord Biotech Ltd is Rated Sell
2026-11-10 10:10:43Concord Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 October 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 November 2026, providing investors with the latest insights into its performance and outlook.
Read MoreConcord Biotech Gains 1.53%: 4 Key Factors Driving the Week’s Volatility
2026-11-07 11:02:53Key Events This Week 2 Nov: Sharp 6.53% decline amid technical downshift 3 Nov: Recovery with 5.66% gain following bearish signals 4 Nov: Intraday high surge of 7.02%, outperforming sector 6 Nov: Intraday low and 6.25% drop despite positive market Week OpenRs.622.65 Week CloseRs.632.15<di...
Read More
Concord Biotech Ltd Hits Intraday Low Amid Price Pressure on 6 Nov 2026
2026-11-06 11:31:46Concord Biotech Ltd experienced a notable intraday decline on 6 Nov 2026, with the stock touching a low of Rs 628, reflecting a 6.87% drop from its previous close. This downturn occurred despite a broadly positive market environment, as the Sensex advanced by 0.6% during the session.
Read More
Concord Biotech Ltd Surges 7.02% to Day's High of Rs 661.9 — Outperforms Sector by 6.83 Percentage Points
2026-11-04 14:38:39The Sensex rose 0.37% on 04 Nov 2026, but Concord Biotech Ltd outpaced the broader market with a 7.02% gain, reaching an intraday high of Rs 661.9. This 6.83 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a market-wide lift.
Read MoreConcord Biotech Gains 1.34%: 3 Key Factors Driving the Week’s Volatility
2026-10-31 11:01:58Key Events This Week 26 Oct: Intraday high surge to Rs.1,319 (+7.34%) 27 Oct: Technical momentum shifts with 6.30% gain 28 Oct: Shares hit intraday low amid 7.66% decline 30 Oct: Week closes at Rs.1,245.30 (+1.25% on day) Week OpenRs.1,228.85 Week CloseRs.1,245.30<div class="stat-change p...
Read More
Concord Biotech Ltd is Rated Sell
2026-10-30 10:11:10Concord Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 Oct 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 October 2026, providing investors with the latest insights into its performance and outlook.
Read More
Concord Biotech Ltd Surges 7.34% to Day's High of Rs 1319 — Outperforms Sector by 6.16 Percentage Points
2026-10-26 15:48:31The Sensex rose 0.66% on 26 Oct 2026, but Concord Biotech Ltd outpaced the broader market with a 7.34% gain, touching an intraday high of Rs 1319. This 6.16 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a market-wide lift.
Read More
Concord Biotech Ltd Faces Technical Downgrade Amid Bearish Momentum
2026-10-21 08:08:13Concord Biotech Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, signalling a transition from sideways trading to a mildly bearish trend. Recent technical indicators including MACD, RSI, and moving averages reveal a complex picture of weakening price momentum, prompting a downgrade in its Mojo Grade from Hold to Sell as of 5 October 2026.
Read MoreAnnouncement under Regulation 30 (LODR)-Allotment
05-Nov-2026 | Source : BSEIntimation of allotment of Bonus equity Shares
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
03-Nov-2026 | Source : BSETranscript of Q2 - FY27 Earnings call held on October 28 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
28-Oct-2026 | Source : BSEPress release - For the Second quarter and half year ended on September 30 2026
Corporate Actions
No Upcoming Board Meetings
Concord Biotech Ltd has declared 755% dividend, ex-date: 24 Jul 26
No Splits history available
Concord Biotech Ltd has announced 1:1 bonus issue, ex-date: 04 Nov 26
No Rights history available